BNTX BioNTech SE Stock Quote

BNTX [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	1.18%	Shs Outstand	238.67M	Perf Week	1.52%
Market Cap	24.88B	Forward P/E	5.96	EPS next Y	17.84	Insider Trans	0.00%	Shs Float	223.06M	Perf Month	6.23%
Income	-	PEG	-	EPS next Q	0.17	Inst Own	10.60%	Short Float	2.64%	Perf Quarter	19.84%
Sales	-	P/S	-	EPS this Y	-300.50%	Inst Trans	0.90%	Short Ratio	1.44	Perf Half Y	22.84%
Book/sh	4.73	P/B	22.47	EPS next Y	1275.00%	ROA	-	Target Price	118.66	Perf Year	220.15%
Cash/sh	5.24	P/C	20.29	EPS next 5Y	-	ROE	-	52W Range	28.00 - 131.00	Perf YTD	30.39%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-31.40%	52W High	-18.86%	Beta	-
Dividend %	-	Quick Ratio	4.00	Sales past 5Y	-	Gross Margin	-	52W Low	279.61%	ATR	5.97
Employees	1800	Current Ratio	4.10	Sales Q/Q	-47.10%	Oper. Margin	-	RSI (14)	53.70	Volatility	4.72% 5.68%
Optionable	Yes	Debt/Eq	0.34	EPS Q/Q	-314.60%	Profit Margin	-	Rel Volume	0.95	Prev Close	110.61
Shortable	Yes	LT Debt/Eq	0.19	Earnings	Nov 10 BMO	Payout	-	Avg Volume	4.09M	Price	106.29
Recom	2.20	SMA20	8.83%	SMA50	1.50%	SMA200	39.59%	Volume	3,863,894	Change	-3.91%

Dec-01-20

Downgrade

BofA Securities

Buy → Neutral

$123 → $126

Aug-03-20

Resumed

Berenberg

Buy

$98

Jul-21-20

Upgrade

BofA Securities

Neutral → Buy

$71 → $105

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Nov-04-19

Initiated

JP Morgan

Overweight

$23

Nov-04-19

Initiated

Canaccord Genuity

Buy

$22

Nov-04-19

Initiated

BofA/Merrill

Buy

$21

Nov-04-19

Initiated

Berenberg

Buy

$25

Jan-27-21 07:51AM	Regeneron says its COVID-19 antibody cocktail still works against new strains in lab test MarketWatch
07:00AM	Sanofi teams up with BioNTech and Pfizer to help fix Europes vaccine shortage MarketWatch
05:49AM	The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech and AstraZeneca Zacks
05:02AM	Sanofi To Manufacture 125 Million COVID-19 Vaccine Doses For Rival Pfizer-BioNTech Benzinga
02:00AM	Sanofi confirms its will supply over 125 millions Pfizer-BioNTech doses to the EU Reuters
01:35AM	Pfizer and BioNTech Get Help From Sanofi on Vaccine Production TheStreet.com
Jan-26-21 01:35PM	Coronavirus update: J&J to release vaccine data next week; strain from Brazil confirmed in US Yahoo Finance
12:59PM	Markets continue to flitter between stimulus hope and COVID concerns: strategist Yahoo Finance Video
12:39PM	J&J CEO: Expect Phase 3 results for its COVID-19 vaccine candidate early next week MarketWatch
11:28AM	Expect Treasury Yields to Start Climbing Again Soon, BCA Says Barrons.com
10:10AM	Breakout Watch: IPO Leader, Pfizer Vaccine Partner MRVI Stock Enters Buy Zone Investor's Business Daily
09:40AM	How Long Will Coronavirus Vaccine Drive Moderna (MRNA) Stock? Zacks
08:19AM	Moderna on track to deliver 200 million doses of its COVID vaccine to U.S. govt by end-June MarketWatch
07:06AM	No serious COVID-19 cases among Israelis given Pfizer shot, minister says Reuters
Jan-25-21 05:46PM	Moderna CEO offers a bleak assessment of COVID-19: Virus to stay with the world 'forever' Yahoo Finance
04:38PM	Merck Scraps 'Inferior' Covid-19 Vaccines; But Shares Recover From Dip Investor's Business Daily
04:36PM	Covid Vaccines: Here's What J&J Has To Do To Undercut Pfizer, Moderna Investor's Business Daily
12:37PM	J&J may share findings from Phase 3 vaccine trial this week MarketWatch
12:20PM	Pfizer (PFE) to Supply 40M Doses of Coronavirus Vaccine to COVAX Zacks
12:18PM	BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine PR Newswire
11:41AM	Is AstraZeneca Stock A Buy After Coronavirus Vaccine Gains U.K. Nod? Investor's Business Daily
11:21AM	Coronavirus update: Moderna launches booster study for South African strain, Merck pulls out of vaccine race Yahoo Finance
10:31AM	Moderna Making Vaccine Booster Shot to Protect Against South African Covid-19 Strain Barrons.com
09:00AM	COVID Vaccine Stocks: How Strong Is BioNTech's Financial Position? Motley Fool
08:24AM	CDC says doses of COVID-19 vaccines can be spaced out by up to 42 days MarketWatch
07:58AM	CDC: Moderna's COVID-19 vaccine can cause allergic reaction in some people MarketWatch
04:42AM	Pfizer-BioNTechs Covid-19 Vaccine Approved By Australias Regulator SmarterAnalyst
01:57AM	Pfizer COVID-19 Vaccine Gets Approved In Australia Benzinga
Jan-24-21 05:01PM	Australia regulator approves Pfizer/BioNTech COVID-19 for use Reuters
08:15AM	BioNTech's Potential Winners Beyond Its COVID Vaccine Motley Fool
Jan-23-21 03:29PM	N.Y. Vaccine Shortage Eases; California Cases Slow: Virus Update Bloomberg
10:30AM	What Does 2021 Hold for BioNTech Stock? Motley Fool
06:44AM	French health body recommends delaying second COVID shot to six weeks after first Reuters
06:04AM	Why BioNTech's Multiple Sclerosis Vaccine Could Be a Game Changer Motley Fool
Jan-22-21 04:08PM	Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New Analysis Motley Fool
02:55PM	Coronavirus update: UK variant may be more deadly than previously thought; CDC says second dose can be delayed Yahoo Finance
12:15PM	BioNTech, Pfizer to sell 40 million doses to lower-income countries MarketWatch
12:00PM	Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19 GlobeNewswire
09:36AM	BioNTech says offering 50 mln needles to extract more vaccine doses Reuters
08:06AM	New Covid-19 Strains May Make Vaccines Less Effective, Fauci Warns Barrons.com
08:00AM	Is Novavax Stock A Buy As Pressure Mounts For More Covid Vaccines? Investor's Business Daily
07:00AM	Pfizer Stock 2021: A Lean, Mean, Covid-Fighting Machine? Investor's Business Daily
Jan-21-21 07:15PM	Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program Motley Fool
04:27PM	Coronavirus update: Biden signs more COVID-19 orders; Pfizer wants to expand sales to states Yahoo Finance
10:11AM	Pfizer (PFE) COVID-19 Vaccine Seems Potent Against UK Strain Zacks
09:58AM	BioNTech investor, amid worry over shortage, vows vaccines to be delivered for 2nd shot Reuters
04:44AM	Norway ready for reduced Pfizer/BioNTech vaccine into Feb Reuters
Jan-20-21 04:13PM	Pfizer Says Covid Jab Could Battle U.K. Variant; Gritstone Expands Its Gain Investor's Business Daily
03:05PM	COVID SCIENCE-S. African virus variant may resist antibody drugs; Pfizer/BioNTech vaccine seems to work vs UK variant Reuters
10:46AM	Pfizer-BioNTech Vaccine Found Effective Against New Coronavirus Strain In Lab Study Benzinga
07:50AM	Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture GlobeNewswire
07:48AM	Another Paper From Pfizer and BioNTech Shows Vaccine Will Protect Against U.K. Strain Barrons.com
Jan-19-21 01:15PM	Coronavirus update: US surpasses 400,000 COVID-19-related deaths Yahoo Finance
07:46AM	European countries struggle to make most of Pfizer COVID-19 vaccine doses Reuters
Jan-18-21 11:34AM	Israel sharing COVID-19 data with Pfizer to help fine-tune vaccine rollout Reuters
08:46AM	Norway advises caution in use of Pfizer vaccine for the most frail Reuters
Jan-17-21 07:02AM	Lebanon inks final deal for 2.1 mln doses of Pfizer-BioNTech vaccine Reuters
Jan-16-21 02:55AM	Pfizer delays Jan. vaccine delivery to Bahrain - health ministry Reuters
Jan-15-21 01:46PM	Why Pfizer Is a Long-Term Investors Friend InvestorPlace
10:55AM	Pfizer Slows Non-U.S. Vaccine Deliveries Amid Manufacturing Changes; Boosts 2021 Dose Goal to 2 Billion TheStreet.com
10:11AM	Coronavirus update: Biden calls for 100 million vaccinations, $121 billion for health care to fight COVID-19 Yahoo Finance
09:43AM	Lebanese parliament approves law paving way for vaccine deal Reuters
Jan-14-21 04:55PM	Pfizer Leads Vaccine Stocks As The Most Trusted Name In Covid-19: IBD/TIPP Investor's Business Daily
03:31PM	Covid-19 Infection Likely to Provide Immunity for at Least Five Months, Study Finds. What That Might Mean. Barrons.com
06:41AM	COVID-19 infection likely to provide immunity for at least 5 months, but people may still transmit virus, study finds MarketWatch
Jan-13-21 05:44PM	J&J Stock Pops After Midstage Test Shows Its Covid Vaccine Is Durable Investor's Business Daily
01:02PM	How the government is handling the COVID-19 vaccine rollout, Biden admin. outlook Yahoo Finance Video
12:48PM	J&J Stock Dips On Report Its Covid Vaccine Is 2 Months Behind Schedule Investor's Business Daily
05:45AM	Baxter Germany to start production of BioNTech/Pfizer vaccine by early March Reuters
Jan-12-21 11:05PM	Analysts Just Published A Bright New Outlook For BioNTech SE's (NASDAQ:BNTX) Simply Wall St.
04:29PM	Pfizer Skids To 200-Day Line On Earnings Outlook That Lagged Some Views Investor's Business Daily
01:16PM	A Guide to Biotech ETF Investing Amid the Coronavirus Crisis Zacks
01:02PM	Pfizer Says It Can Quickly Develop Vaccines for Future Covid-19 Variants Barrons.com
11:03AM	AstraZenecaOxford COVID-19 shot could be authorized Jan. 29, says EU medical regulator MarketWatch
10:37AM	COVID-19 Vaccine Production to Ramp Up Zacks
10:22AM	Covid-19 Vaccinations Promise to Ramp Up Zacks
09:57AM	Pfizer has produced more than 70 mln COVID-19 vaccine doses-CEO Reuters
09:18AM	Moderna (MRNA) Stock Up on Vaccine Pipeline Expansion Plan Zacks
08:16AM	Uber, Moderna to collaborate on supporting COVID-19 vaccine uptake MarketWatch
08:00AM	Uber and Moderna Team Up to Boost Vaccine Awareness Bloomberg
06:05AM	2021's buzziest phrase has already been a winner Yahoo Finance
Jan-11-21 06:04PM	Why BioNTech Crushed the Market on Monday Motley Fool +8.48%
04:34PM	BioNTech Surges On Its Plan To Make 2 Billion Covid Vaccine Doses In 2021 Investor's Business Daily
02:03PM	BioNTech to offer vaccine to its own workers Reuters
12:29PM	BioNTech CEO Says a Version of Its Covid Vaccine With Less Stringent Storage Requirements Could Come This Year Barrons.com
01:00AM	CORRECTED-RPT-Scarce doses and empty vaccination centres: Germany's vaccine rollout headache Reuters
Jan-10-21 11:25PM	Malaysia buys additional 12.2 million doses of Pfizer-BioNTech COVID-19 vaccine Reuters
07:00AM	CORRECTED-Scarce doses and empty vaccination centres: Germany's vaccine rollout headache Reuters
Jan-09-21 01:00AM	mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrow Bloomberg
Jan-08-21 04:32PM	BioNTech Jumps As Study Suggests Covid Vaccine Might Block New Strains Investor's Business Daily +7.15%
03:37PM	COVID SCIENCE-Pfizer/BioNTech vaccine works against virus variants in lab; arthritis drugs improve COVID-19 survival Reuters
03:14PM	Biden plans to distribute COVID-19 vaccine doses immediately MarketWatch
01:23PM	20 Biggest Questions in Science Insider Monkey
12:59PM	Coronavirus update: Pfizer says vaccine may work against UK and South Africa strains; vaccinations to increase under Biden administration Yahoo Finance
12:29PM	Modernas COVID-19 vaccine becomes third shot authorized for use in U.K. MarketWatch
10:55AM	FDA Commissioner Says States Should Expand Covid-19 Vaccine Eligibility Barrons.com
10:41AM	As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade InvestorPlace
10:00AM	Dow Jones Today, Stocks Jump Despite Payrolls Miss; Bitcoin Tops $41,000, Micron Earnings Beat Investor's Business Daily
09:47AM	Germany secured 50 mln vaccine doses from CureVac, BioNTech on top of EU supplies - document Reuters
09:00AM	Don't Expect Covid-19 Research to Deliver Certainty Bloomberg

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/II trial for prostate cancer; BNT113, which is in Phase I trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116, which is in preclinical trail for non-small cell lung cancer. It also develops neo-antigen specific immunotherapies, such as RO7198457, which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT152 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT212 for pancreatic and other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I/II clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Eli Lilly and Company; Bayer AG; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; Regeneron Pharmaceuticals, Inc.; and InstaDeep Ltd. The company was founded in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience